US-licensed Combined Vaccine Against Tetanus & Diphtheria, Given With US-licensed Vaccine Against Meningococcal Disease

Clinical trial NCT00282295 · COMPLETED

Trial details

NCT number: NCT00282295
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Acellular Pertussis Tetanus Diphtheria

Start date: 2006-01-25
Primary completion: 2006-08-08
Enrollment: 1344

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.